These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7503509)

  • 41. Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines.
    Douty B; Wayland B; Ala PJ; Bower MJ; Pruitt J; Bostrom L; Wei M; Klabe R; Gonneville L; Wynn R; Burn TC; Liu PC; Combs AP; Yue EW
    Bioorg Med Chem Lett; 2008 Jan; 18(1):66-71. PubMed ID: 18037290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and hypoglycemic activity of some new flavone derivatives. 4th communication: 6-flavonyl-2,4-thiazolidinediones.
    Bozdağ-Dündar O; Waheed A; Verspohl EJ; Ertan R
    Arzneimittelforschung; 2001; 51(8):623-7. PubMed ID: 11556121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and hypnotic activity of new 4-thiazolidinone and 2-thioxo-4,5-imidazolidinedione derivatives.
    Ergenç N; Capan G; Günay NS; Ozkirimli S; Güngör M; Ozbey S; Kendi E
    Arch Pharm (Weinheim); 1999 Oct; 332(10):343-7. PubMed ID: 10575366
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antihyperglycemic effects of newly synthesized 6,7-bis[2-(substitutedphenyl)-4-oxothiazolidin3yl1 quinoxaline 2,3-(1 FH, 4 H)-diones.
    Pawar PY; Bhise SB
    Indian J Physiol Pharmacol; 2006; 50(4):431-4. PubMed ID: 17402276
    [No Abstract]   [Full Text] [Related]  

  • 45. Synthesis and biological evaluation of thiazolidine-2,4-dione and 2,4-thione derivatives as inhibitors of translation initiation.
    Chen H; Fan YH; Natarajan A; Guo Y; Iyasere J; Harbinski F; Luus L; Christ W; Aktas H; Halperin JA
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5401-5. PubMed ID: 15454234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and anti-inflammatory activity of new arylidene-thiazolidine-2,4-diones as PPARgamma ligands.
    Barros CD; Amato AA; de Oliveira TB; Iannini KB; Silva AL; Silva TG; Leite ES; Hernandes MZ; Alves de Lima Mdo C; Galdino SL; Neves Fde A; Pitta Ida R
    Bioorg Med Chem; 2010 Jun; 18(11):3805-11. PubMed ID: 20471839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New antitumor imidazo[2,1-b]thiazole guanylhydrazones and analogues.
    Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Calonghi N; Cappadone C; Farruggia G; Zini M; Stefanelli C; Masotti L; Radin NS; Shoemaker RH
    J Med Chem; 2008 Feb; 51(4):809-16. PubMed ID: 18251494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and aldose reductase inhibitory activity of 2-substituted-6-fluoro-2,3-dihydrospiro [4H-1-benzopyran-4, 4'-imidazolidine]-2',5'-diones.
    Yamaguchi T; Miura K; Usui T; Unno R; Matsumoto Y; Fukushima M; Mizuno K; Kondo Y; Baba Y; Kurono M
    Arzneimittelforschung; 1994 Mar; 44(3):344-8. PubMed ID: 8192700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antimycobacterial evaluation of novel hybrid arylidene thiazolidine-2,4-diones.
    Ponnuchamy S; Kanchithalaivan S; Ranjith Kumar R; Ali MA; Choon TS
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1089-93. PubMed ID: 24472146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Synthesis and structure of substituted bromo and nitrobenzyl benzylidene imidazolidinediones and thiazolidinediones].
    Amorim EL; Brandao SS; Cavalcanti CO; Galdino SL; Pitta IR; Luu-Duc C
    Ann Pharm Fr; 1992; 50(2):103-11. PubMed ID: 1471825
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and antihyperglycemic activity profiles of novel thiazolidinedione derivatives.
    Bhat BA; Ponnala S; Sahu DP; Tiwari P; Tripathi BK; Srivastava AK
    Bioorg Med Chem; 2004 Nov; 12(22):5857-64. PubMed ID: 15498661
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel euglycemic and hypolipidemic agents. 1.
    Lohray BB; Bhushan V; Rao BP; Madhavan GR; Murali N; Rao KN; Reddy AK; Rajesh BM; Reddy PG; Chakrabarti R; Vikramadithyan RK; Rajagopalan R; Mamidi RN; Jajoo HK; Subramaniam S
    J Med Chem; 1998 May; 41(10):1619-30. PubMed ID: 9572887
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and chemiluminescent high throughput screening for inhibition of acetylcholinesterase activity by imidazo[2,1-b]thiazole derivatives.
    Andreani A; Granaiola M; Guardigli M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Roda A
    Eur J Med Chem; 2005 Dec; 40(12):1331-4. PubMed ID: 16129518
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis of imidazo[2,1-b]thiazoles linked to an unprotected carbohydrate moiety.
    Barradas JS; Errea MI; D'Accorso NB
    Carbohydr Res; 2012 Jul; 355():79-86. PubMed ID: 22595774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel antidiabetic and hypolipidemic agents. 5. Hydroxyl versus benzyloxy containing chroman derivatives.
    Reddy KA; Lohray BB; Bhushan V; Reddy AS; Rao Mamidi NV; Reddy PP; Saibaba V; Reddy NJ; Suryaprakash A; Misra P; Vikramadithyan RK; Rajagopalan R
    J Med Chem; 1999 Aug; 42(17):3265-78. PubMed ID: 10464013
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thiazole analog as stearoyl-CoA desaturase 1 inhibitor.
    Li CS; Belair L; Guay J; Murgasva R; Sturkenboom W; Ramtohul YK; Zhang L; Huang Z
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5214-7. PubMed ID: 19632834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones.
    Willson TM; Cobb JE; Cowan DJ; Wiethe RW; Correa ID; Prakash SR; Beck KD; Moore LB; Kliewer SA; Lehmann JM
    J Med Chem; 1996 Feb; 39(3):665-8. PubMed ID: 8576907
    [No Abstract]   [Full Text] [Related]  

  • 58. Synthesis and hypoglycemic activity of some new flavone derivatives. 2nd communication: 4'-flavonyl-2,4-thiazolidinediones.
    Bozdağ O; Verspohl EJ; Ertan R
    Arzneimittelforschung; 2000 Jun; 50(6):539-43. PubMed ID: 10918947
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thiazolidine-2,4-diones: progress towards multifarious applications.
    Jain VS; Vora DK; Ramaa CS
    Bioorg Med Chem; 2013 Apr; 21(7):1599-620. PubMed ID: 23419324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis, biological evaluation and molecular modeling studies of arylidene-thiazolidinediones with potential hypoglycemic and hypolipidemic activities.
    da Costa Leite LF; Veras Mourão RH; de Lima Mdo C; Galdino SL; Hernandes MZ; de Assis Rocha Neves F; Vidal S; Barbe J; da Rocha Pitta I
    Eur J Med Chem; 2007 Oct; 42(10):1263-71. PubMed ID: 17448573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.